Korean J Urol.
1988 Feb;29(1):133-141.
The Use of Enoxacin (B-Mark(TM)) in Urinary Tract Infections
- Affiliations
-
- 1East City Hospital, Seoul, Korea.
Abstract
- A new synthetic pyridone carboxylic antimicrobial agent, Enoxacin (B-Mark(TM)) was administered orally in 37 cases of genitourinary tract infection and following results were obtained. 1. Among 12 cases of acute simple cystitis, the cure rate was 91.7%. 2. Among 6 cases of chronic complicated urinary tract infections, the cure rate was 66.7 %. 3. Among 9 cases of gonorrheal urethritis, the cure rate was 88.9%. 4. Among 10 cases of nongonorrheal urethritis, the cure rate was 60%. There was no serious side effects but mild G-I symptoms such as nausea, indigestion and fatigability were found. The results suggest that Enoxacin (B-Mark(TM)) is a useful antibacterial agent in the treatment of urinary tract infections, especially in acute simple cystitis and gonorrheal urethritis.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Effect of Enoxacin(Flumark) in Urinary Tract Infection - Clinical and Antimicrobial Susceptibility Evaluation-
- Effects of enoxacin and ciprofloxacin on the theophylline metabolism in humans
- Treatment of urinary tract infections
- Clinical Guideline for the Diagnosis and Treatment of Urinary Tract Infections: Asymptomatic Bacteriuria, Uncomplicated & Complicated Urinary Tract Infections, Bacterial Prostatitis
- A Case of Gram - Negative Toeweb infection
